Trademark Overview
On Thursday, August 14, 2025, a trademark application was filed for NORDICCTX-III with the United States Patent and Trademark Office. The USPTO has given the NORDICCTX-III trademark a serial number of 79433974. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, October 2, 2025. This trademark is owned by Nordic Bioscience A/S. The NORDICCTX-III trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Diagnostic biomarker reagents for medical purposes; biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; biomarker assays to identify disease activity; biomarker assays to quantify disease activity; biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; diagnostic agents for medical use; diagnostic reagents for medical use; clinical diagnostic agents; clinical diagnostic reagents; diagnostic preparations for medical purposes, diagnostic substances and diagnostic materials; medical diagnostic test strips; diagnostic preparations for medical purposes.
Design and development of the following goods: blood-based biomarkers for the identification, quantification and analysis of disease activity; design and development of the following goods: diagnostic biomarker reagents for medical purposes, for pharmaceutical purposes and for scientific purposes; design and development of the following goods: biochemical and pharmaceutical assays and medical samples; design and development of the following goods: biomarkers for individual use or combined for the tracking of tissue formation, development or tissue degradation; pharmaceutical and scientific research relating to the following fields: biomarkers and the detection of biomarkers; identification of predictive and prognostic biomarkers for clinical trials; identifing patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to the following fields: clinical trials; clinical trials; analysis of pharmacodynamic data; analysis of data...
